On June 24, 2022, the United States Supreme Court issued a decision in the landmark case, Dobbs v. Jackson Women’s Health Organization — overturning the federal right to abortion. Since then, states have taken steps to either protect or further undermine access to reproductive health care and abortion services. 

Our co-faculty director, Michele Goodwin, and other experts have provided extensive analysis and commentary on the impact of Dobbs as well as abortion and reproductive rights around the world: Oscar A. Cabrera, Sonia L. Canzater, Susan Crockin, Rolonda Donelson, Ivonne Garza, Lawrence O. Gostin, Natalia Acevedo Guerrero, Natasha Martín Lauletta, Francesca Nardi, Gloria Orrego-Hoyos, Aiseosa Osaghae, Sheela Ranganathan, Suhasini Ravi, Rebecca Reingold, Silvia Serrano-Guzmán, Andrew Twinamatsiko, Sarah Wetter.

What to Know

Michele Goodwin’s segment begins at 1:26.

The October 2023 Supreme Court Term 

Michele Goodwin’s segment begins at 2:09.

Responses at the State Level

Michele Goodwin in conversation with Slate’s Amicus with Dahlia Lithwick.

Access to Abortion Medication

Graphic stating, "When Congress gave FDA the authority to regulate drug approval, it recognized that the scientific agency was in the best position to make decisions in the interest of public health."

Immediate Responses

Katie Keith speaking at the Aspen Ideas festival following the Dobbs decision.

Around the World


The Latest